Vertex Pharmaceuticals delivered fourth quarter results that outpaced Wall Street's revenue expectations, driven by continued expansion in cystic fibrosis therapies and early contributions from ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Enabling patients to order prescription medications directly from ...

IGC Pharma (IGC) announced the publication of a new interview with CEO Ram Mukunda, now available as part of the IMS Spotlight Series.In the interview, Ram Mukunda discusses IGC’s strategic expansion ...

As the pharma patent cliff approaches, delve into which important drugs are about to lose exclusivity and how the industry is reacting.

Here's the interview I did with biotech analyst Bhavneesh Sharma a couple months ago. With continued success stories in AI impacting biotech and pharma, we should expect more investment ideas over ...

In a recent interview with Fierce, Ostro co-founders Ahmed Elsayyad and Chase Feiger, M.D. shared how artificial intelligence is reshaping the pharma marketing landscape—from regulatory-compliant ...

LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of ...

Ahmad Doroudian, Ph.D., is Chief Executive Officer and Director of BetterLife Pharma Inc. Dr. Doroudian is an accomplished executive with over 25 years’ experience in management and development of ...

In a recent interview with Fierce, Brie Thomas, senior vice president of sales at Swoop, shared insights on the dramatic transformation of pharma marketing over the past few years—particularly the ...

ORLANDO, FLORIDA / ACCESS Newswire / July 25, 2025 / RedChip Companies will air an interview with Lantern Pharma Inc. (Nasdaq:LTRN) on the RedChip Small Stocks, Big Money™ show, a sponsored program on ...

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) beat Wall Street’s revenue expectations in Q4 CY2025 as sales rose to $874 million. Correction note:The previous version of this report had ...